Skip to content

Adopting different incision closure methods in bilateral joint arthroplasty: a prospective randomized controlled study.

Adopting different incision closure methods in bilateral joint arthroplasty: a prospective randomized controlled study.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025730
Enrollment
Unknown
Registered
2019-09-06
Start date
2019-10-05
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with bilateral hip and knee arthroplasty

Interventions

Experimental group:tissue adhesive combined with intradermal suture
Control group:intradermal suture

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Bilateral joint replacement with the same approach, the same prosthesis; 2. Informed consent for this study.

Exclusion criteria

Exclusion criteria: 1. Previous surgical site history or infection history; 2. Scar or suspected infection on the skin at the operation site; 3. Previous history of keloid; 4. Psoriasis, eczema and other skin diseases that affect wound healing; 5. Peripheral vascular diseases such as venous thrombosis of lower limbs or arterial occlusion of lower limbs; 6. Known allergy to skin adhesive ingredients; 7. Have a history of malignant tumor; 8. Bilateral joint replacement cannot be performed for various reasons.

Design outcomes

Primary

MeasureTime frame
Suture time;Adverse events such as poor wound healing or persistent exudation;Total cost of incisions during hospitalization;Wound healing rating;Incision Hollander Score;Wound Healing Vancouver Score;Satisfaction Likert Score;VAS score of incision satisfaction;ROM,KSS,Harris;Adverse events such as superficial infection or deep infection or incision dehiscence;Total incision-related costs;

Secondary

MeasureTime frame
length of stay;Number of application replacement;

Countries

China

Contacts

Public ContactChaiwei

Chinese PLA General Hospital

chaiwei301@163.com+86 13601372998

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026